Astrid Kemgang

1.1k total citations
11 papers, 573 citations indexed

About

Astrid Kemgang is a scholar working on Hepatology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Astrid Kemgang has authored 11 papers receiving a total of 573 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 8 papers in Epidemiology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Astrid Kemgang's work include Liver Diseases and Immunity (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Liver Disease and Transplantation (2 papers). Astrid Kemgang is often cited by papers focused on Liver Diseases and Immunity (8 papers), Liver Disease Diagnosis and Treatment (6 papers) and Liver Disease and Transplantation (2 papers). Astrid Kemgang collaborates with scholars based in France, Italy and Canada. Astrid Kemgang's co-authors include Christophe Corpechot, Olivier Chazouillères, Farid Gaouar, Ahmed El Naggar, Dominique Wendum, Raoul Poupon, Fabrice Carrat, Chantal Housset, Sara Lemoinne and Karima Ben Belkacem and has published in prestigious journals such as Gastroenterology, Gut and Journal of Hepatology.

In The Last Decade

Astrid Kemgang

11 papers receiving 571 citations

Peers

Astrid Kemgang

EPIDE

HEPAT

PRM

SURGE

Andy Yu United States

Amir Houshang Mohammad Alizadeh Iran

Richard Aspinall United Kingdom

Tankut İlter Türkiye

Kubilay Çınar Türkiye

H Schwacha Germany

Gloria Sánchez‐Antolín Spain

Fadi Antaki United States

Yong Lv China

Stefan Bourgeois Belgium

Andy Yu United States

Astrid Kemgang

296 ×0.7

EPIDE

234 ×0.6

HEPAT

99 ×0.6

PRM

181 ×1.4

SURGE

50 ×0.6

Citations per year, relative to Astrid Kemgang Astrid Kemgang (= 1×) peers Andy Yu

Countries citing papers authored by Astrid Kemgang

Since Specialization

Citations

This map shows the geographic impact of Astrid Kemgang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Kemgang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Kemgang more than expected).

Fields of papers citing papers by Astrid Kemgang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Kemgang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Kemgang. The network helps show where Astrid Kemgang may publish in the future.

Co-authorship network of co-authors of Astrid Kemgang

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Kemgang. A scholar is included among the top collaborators of Astrid Kemgang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Kemgang. Astrid Kemgang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Mostafavi, Nahid, Annika Bergquist, Olivier Chazouillères, et al.. (2023). The association between cholestatic biochemical markers and clinical symptoms in patients with non-end-stage primary sclerosing cholangitis. Journal of Hepatology. 78. S408–S408. 1 indexed citations

Ruffin, Manon, et al.. (2021). Risk factors for Pseudomonas aeruginosa airway infection and lung function decline in children with cystic fibrosis. Journal of Cystic Fibrosis. 21(1). 45–51. 17 indexed citations

Corvol, Harriet, Sandra de Miranda, Lydie Lemonnier, et al.. (2020). First Wave of COVID-19 in French Patients with Cystic Fibrosis. Journal of Clinical Medicine. 9(11). 3624–3624. 24 indexed citations

Lemoinne, Sara, Astrid Kemgang, Karima Ben Belkacem, et al.. (2019). Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis. Gut. 69(1). 92–102. 146 indexed citations

Lemoinne, Sara, Nora Cazzagon, S. El Mouhadi, et al.. (2019). Simple Magnetic Resonance Scores Associate With Outcomes of Patients With Primary Sclerosing Cholangitis. Clinical Gastroenterology and Hepatology. 17(13). 2785–2792.e3. 49 indexed citations

Cazzagon, Nora, Sara Lemoinne, S. El Mouhadi, et al.. (2019). The Complementary Value of Magnetic Resonance Imaging and Vibration-Controlled Transient Elastography for Risk Stratification in Primary Sclerosing Cholangitis. The American Journal of Gastroenterology. 114(12). 1878–1885. 25 indexed citations

Lemoinne, Sara, Astrid Kemgang, Karima Ben Belkacem, et al.. (2019). PS-126-Fungi participate in the dysbiosis of gut microbiota in patients with primary sclerosing cholangitis. Journal of Hepatology. 70(1). e78–e78. 1 indexed citations

Ponsioen, Cyriel Y., Urban Arnelo, Annika Bergquist, et al.. (2017). Multicenter randomized trial comparing short-term stenting versus balloon dilatation for dominant strictures in primary sclerosing cholangitis. Journal of Hepatology. 66(1). S1–S2. 4 indexed citations

Sasso, M., Astrid Kemgang, Farid Gaouar, et al.. (2015). Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy. Ultrasound in Medicine & Biology. 42(1). 92–103. 108 indexed citations

10.

Corpechot, Christophe, Farid Gaouar, Ahmed El Naggar, et al.. (2014). Baseline Values and Changes in Liver Stiffness Measured by Transient Elastography Are Associated With Severity of Fibrosis and Outcomes of Patients With Primary Sclerosing Cholangitis. Gastroenterology. 146(4). 970–979.e6. 196 indexed citations

11.

Corpechot, Christophe, Farid Gaouar, Ahmed El Naggar, et al.. (2014). O84 LIVER STIFFNESS ASSESSED BY FIBROSCAN IS A MAJOR PROGNOSTIC FACTOR IN PRIMARY SCLEROSING CHOLANGITIS. Journal of Hepatology. 60(1). S34–S34. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact